A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol.
Hajda J, Lehmann M, Krebs O, Kieser M, Geletneky K, Jäger D, Dahm M, Huber B, Schöning T, Sedlaczek O, Stenzinger A, Halama N, Daniel V, Leuchs B, Angelova A, Rommelaere J, Engeland CE, Springfeld C, Ungerechts G.
Hajda J, et al. Among authors: kieser m.
BMC Cancer. 2017 Aug 29;17(1):576. doi: 10.1186/s12885-017-3604-y.
BMC Cancer. 2017.
PMID: 28851316
Free PMC article.
Clinical Trial.